Fluid management and vasopressor use during colorectal surgery: the search for the optimal balance

Abstract

Background Although it is known that excessive intraoperative fuid and vasopressor agents are detrimental for anastomotic healing, optimal anesthesiology protocols for colorectal surgery are currently lacking. Objective To scrutinize the current hemodynamic practice and vasopressor use and their relation to colorectal anastomotic leakage. Design A secondary analysis of a previously published prospective observational study: the LekCheck study. Study setting Adult patients undergoing a colorectal resection with the creation of a primary anastomosis. Outcome measures Colorectal anastomotic leakage (CAL) within 30 days postoperatively, hospital length of stay and 30-day mortality. Results Of the 1548 patients, 579 (37%) received vasopressor agents during surgery. Of these, 201 were treated with solely noradrenaline, 349 were treated with phenylephrine, and 29 received ephedrine. CAL rate signifcantly difered between the patients receiving vasopressor agents during surgery compared to patients without (11.8% vs 6.3%, p<0.001). CAL was signifcantly higher in the group receiving phenylephrine compared to noradrenaline (14.3% vs 6%, p<0.001). Vasopressor agents were used more often in patients treated with Goal Directed Therapy (47% vs 34.6%, p<0.001). There was a higher mortality rate in patients with vasopressors compared to the group without (2.8% vs 0.4%, p=0.01, OR 3.8). Mortality was higher in the noradrenaline group compared to the phenylephrine and those without vasopressors (5% vs. 0.4% and 1.7%, respectively, p<0.001). In multivariable analysis, patients with intraoperative vasopressor agents had an increased risk to develop CAL (OR 2.1, CI 1.3–3.2, p=0.001). Conclusion The present study contributes to the evidence that intraoperative use of vasopressor agents is associated with a higher rate of CAL. This study helps to create awareness on the (necessity to) use of vasopressor agents in colorectal surgery patients in striving for successful anastomotic wound healing. Future research will be required to balance vasopressor agent dosage in view of colorectal anastomotic leakage.